Literature DB >> 17454704

Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco-dependent smokers.

Ivan Berlin1, Maria J Gasior, Eric T Moolchan.   

Abstract

Variations in nicotine metabolism influence smoking patterns. Differences between sexes or related to sex hormones may affect nicotine metabolism. Because smoking initiation starts during adolescence, observations gathered from adolescent smokers might broaden our understanding of such sex-based differences. We tested the hypothesis that nicotine metabolism--as indexed primarily by the ratio of trans-3'-hydroxycotinine (3HC) to cotinine--is more rapid among adolescent girl smokers compared with boys and that regular use of hormonal contraceptives influences nicotine and cotinine metabolism. We also hypothesized that more rapid nicotine metabolism is associated with higher nicotine dependence as indexed by smoking frequency and morning urgency. Plasma samples of nicotine, cotinine, and 3HC concentrations were obtained from 120 adolescents (36 boys). Plasma nicotine and cotinine concentrations were similar in boys and girls. Median plasma 3HC concentrations were 44.45 ng/ml for girls versus 35.74 ng/ml for boys (p = .025), and median plasma 3HC-cotinine ratios were significantly higher in girls than in boys (0.317 vs. 0.253, p = .025). After stratifying girls into two groups based on use versus nonuse of hormonal contraception, plasma 3HC-cotinine ratios in girls using hormonal contraception (0.47) were substantially higher (p<.0001) than in boys (0.25) and were significantly higher than in girls not using hormonal contraception (0.28). Controlling for cigarettes smoked per day, ethnicity, and age did not modify these results. Although plasma nicotine, cotinine, or 3HC concentrations were significantly lower in less dependent adolescent smokers, nicotine and cotinine metabolite ratios were similar. This study showed that hormonal contraception in adolescent girls may accelerate cotinine metabolism, an effect likely related to induction of cytochrome P450 2A6 and independent of ethnicity and cigarette consumption. Prospective controlled studies are needed to further evaluate the role of hormonal contraception in patterns of adolescent smoking and nicotine metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17454704     DOI: 10.1080/14622200701243193

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  25 in total

Review 1.  Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio.

Authors:  Cheyenne E Allenby; Kelly A Boylan; Caryn Lerman; Mary Falcone
Journal:  J Neuroimmune Pharmacol       Date:  2016-02-12       Impact factor: 4.147

2.  A link between adolescent nicotine metabolism and smoking topography.

Authors:  Eric T Moolchan; Craig S Parzynski; Maria Jaszyna-Gasior; Charles C Collins; Michelle K Leff; Debra L Zimmerman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

3.  Assessment of serum cotinine in patients with chronic heart failure: self-reported versus objective smoking behaviour.

Authors:  Nicole Ebner; Gabor Földes; Tibor Szabo; Matthias Tacke; Susann Fülster; Anja Sandek; Wolfram Doehner; Stefan D Anker; Stephan von Haehling
Journal:  Clin Res Cardiol       Date:  2012-08-10       Impact factor: 5.460

Review 4.  Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.

Authors:  Gail D Anderson; Lingtak-Neander Chan
Journal:  Clin Pharmacokinet       Date:  2016-11       Impact factor: 6.447

5.  Nicotine metabolism and addiction among adolescent smokers.

Authors:  Mark L Rubinstein; Saul Shiffman; Anna-Barbara Moscicki; Michelle A Rait; Saunak Sen; Neal L Benowitz
Journal:  Addiction       Date:  2012-10-05       Impact factor: 6.526

Review 6.  Sex and gender differences in substance use disorders.

Authors:  R Kathryn McHugh; Victoria R Votaw; Dawn E Sugarman; Shelly F Greenfield
Journal:  Clin Psychol Rev       Date:  2017-11-10

7.  Use of hormonal contraceptives and smoking cessation: A preliminary report.

Authors:  Alicia M Allen; Samantha Carlson; Lynn E Eberly; Dorothy Hatsukami; Megan E Piper
Journal:  Addict Behav       Date:  2017-08-04       Impact factor: 3.913

Review 8.  Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation.

Authors:  Andrea H Weinberger; Philip H Smith; Sharon S Allen; Kelly P Cosgrove; Michael E Saladin; Kevin M Gray; Carolyn M Mazure; Cora Lee Wetherington; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

9.  Evaluating metronidazole as a novel, safe CYP2A6 phenotyping probe in healthy adults.

Authors:  Stephani L Stancil; Robin E Pearce; Rachel F Tyndale; Gregory L Kearns; Carrie A Vyhlidal; J Steven Leeder; Susan Abdel-Rahman
Journal:  Br J Clin Pharmacol       Date:  2019-03-12       Impact factor: 4.335

10.  Menstrual phase and depressive symptoms differences in physiological response to nicotine following acute smoking abstinence.

Authors:  Sharon S Allen; Alicia M Allen; Michael Kotlyar; Scott Lunos; Mustafa Al'absi; Dorothy Hatsukami
Journal:  Nicotine Tob Res       Date:  2012-11-15       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.